After participating in this educational activity, attendees should be able to:
1. Describe the pathophysiology and treatment goals of lupus nephritis.
2. Compare the efficacy and safety of immunosuppressants used in lupus nephritis
3. Recognize alternatives to standard induction and maintenance therapies in patients with relapsing lupus nephritis
Jenna Lee, PharmD
PGY1 Community-Based Pharmacy Resident
Baystate Medical Center
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 ACPE Contact Hours